Anti-allergic drug azelastine suppresses colon tumorigenesis by directly targeting ARF1 to inhibit IQGAP1-ERK-Drp1-mediated mitochondrial fission

This study aimed to screen novel anticancer strategies from FDA-approved non-cancer drugs and identify potential biomarkers and therapeutic targets for colorectal cancer (CRC). Methods: A library consisting of 1056 FDA-approved drugs was screened for anticancer agents. WST-1, colony-formation, flow...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Hui-Fang, Xu, Wen Wen, Li, Yang-Jia, He, Yan, Zhang, Wei-Xia, Liao, Long, Zhang, Qi-Hua, Han, Lei, Yin, Xing-Feng, Zhao, Xiao-Xu, Pan, Yun-Long, Li, Bin, He, Qing-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778598/
https://www.ncbi.nlm.nih.gov/pubmed/33408784
http://dx.doi.org/10.7150/thno.48698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778598/
https://www.ncbi.nlm.nih.gov/pubmed/33408784
http://dx.doi.org/10.7150/thno.48698

Ejemplares similares